logo

Last Update

This profile was last updated on 9/13/2016 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Donald Payan?

Donald G. Payan

Executive Vice President and President

Discovery

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Discovery

Background Information

Employment History

itqpl


Cso

Khepri.com


Affiliations

Howard Hughes Medical Institute

Member


Catalyst Biosciences , Inc.

Member of SCIENTIFIC ADVISORY BOARD


The Vaccine Company

Board Member


Zengen , Inc.

Board Member


Gladstone Institute At The University Of California

Member, Advisory Board


Rigel Pharmaceuticals , Inc.

Executive Vice President and Chief Scientific Officer


Kinexis , Inc.

Board Member


Education

B.S.

Stanford University


M.D.

Stanford University


Web References(170 Total References)


rigel management team

www.rigel.com [cached]

Donald G. Payan, M.D. - Executive Vice President and President, Discovery & Research
Donald G. Payan, M.D., one of Rigel's co-founders, has been a member of our Board of Directors since July 1996 and was appointed Executive Vice President and President of Discovery & Research in February 2008 . From January 1997 to February 2008, Dr. Payan served as our Executive Vice President and Chief Scientific Officer. Dr. Payan also served as Rigel's Chief Operating Officer from January 1997 to July 1998 and as our President and Chief Executive Officer from July 1996 to January 1997. Prior to Rigel, Dr. Payan was Vice President of AxyS Pharmaceuticals (now Celera), a biopharmaceutical company, and Executive Vice President and Chief Scientific Officer of Khepri Pharmaceuticals, which he founded and subsequently merged with AxyS Pharmaceuticals. Dr. Payan is a former Professor at the University of California, San Francisco and Member of the Howard Hughes Medical Institute. Dr. Payan holds an M.D. and a B.S. from Stanford University and completed his residencies and fellowships at the Massachusetts General Hospital and Harvard Medical School.


apipharmaceuticals.com

Donald Payan, MD
Director Dr. Payan is a co-founder of Rigel Pharmaceutical. He was its first CEO and President. He has been a member of its Board of Directors since July 1996 and was appointed Executive Vice President and President of Discovery & Research in February 2008. From January 1997 to February 2008, Dr. Payan served as our Executive Vice President and Chief Scientific Officer. Prior to Rigel, Dr. Payan was Vice President of AxyS Pharmaceuticals (now Celera), a biopharmaceutical company, and Executive Vice President and Chief Scientific Officer of Khepri Pharmaceuticals, which he founded and subsequently merged with AxyS Pharmaceuticals. Dr. Payan is a former Professor at the University of California, San Francisco and Member of the Howard Hughes Medical Institute.


senior management: Rigel Pharmaceuticals

www.rigel.com [cached]

Donald G. Payan, MD
Donald G. Payan, M.D., one of Rigel's co-founders, has been a member of our Board of Directors since July 1996 and was appointed Executive Vice President and President of Discovery and Research in February 2008 . From January 1997 to February 2008, Dr. Payan served as our Executive Vice President and Chief Scientific Officer. Dr. Payan also served as Rigel's Chief Operating Officer from January 1997 to July 1998 and as our President and Chief Executive Officer from July 1996 to January 1997. Prior to Rigel, Dr. Payan was Vice President of AxyS Pharmaceuticals (now Celera), a biopharmaceutical company, and Executive Vice President and Chief Scientific Officer of Khepri Pharmaceuticals, which he founded and subsequently merged with AxyS Pharmaceuticals. Dr. Payan is a former Professor at the University of California, San Francisco and Member of the Howard Hughes Medical Institute. Dr. Payan holds an M.D. and a B.S. from Stanford University and completed his residencies and fellowships at the Massachusetts General Hospital and Harvard Medical School.


senior management: Rigel Pharmaceuticals

www.rigel.com [cached]

Donald G. Payan, MD
Donald G. Payan, M.D., one of Rigel's co-founders, has been a member of our Board since July 1996 and was appointed Executive Vice President and President of Discovery and Research in February 2008 . From January 1997 to February 2008, Dr. Payan served as our Executive Vice President and Chief Scientific Officer. Dr. Payan also served as Rigel's Chief Operating Officer from January 1997 to July 1998 and as our President and Chief Executive Officer from July 1996 to January 1997. Prior to Rigel, Dr. Payan was Vice President of AxyS Pharmaceuticals (now Celera), a biopharmaceutical company, and Executive Vice President and Chief Scientific Officer of Khepri Pharmaceuticals, which he founded and subsequently merged with AxyS Pharmaceuticals. Dr. Payan is a former Professor at the University of California, San Francisco and Member of the Howard Hughes Medical Institute. Dr. Payan holds an M.D. and a B.S. from Stanford University and completed his residencies and fellowships at the Massachusetts General Hospital and Harvard Medical School.


www.biocetera.com

This marks our second collaboration with AstraZeneca in the area of immunology and we are confident it will be as mutually rewarding as the first," said Donald Payan, M.D., executive vice president and president of Discovery and Research at Rigel Pharmaceuticals.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory